《中国成人糖尿病前期干预的专家共识(2023版)》解读  

Interpretation of Intervention for adults with pre-diabetes:a Chinese expert consensus(2023 edition)

作　　者：孙增彩 程斌[2] 王媛媛 孙英霞[1] SUN Zengcai;CHENG Bin;WANG Yuanyuan;SUN Yingxia(College of Acupuncture Moxibustion and Tuina,Shandong University of Traditional Chinese Medicine,Jinan,Shandong 250014,China;不详)

机构地区：[1]山东中医药大学针灸推拿学院,山东济南250014 [2]山东中医药大学附属医院针灸科,山东济南250014

出　　处：《中国临床研究》2025年第4期618-622,共5页Chinese Journal of Clinical Research

基　　金：山东省重点研发计划项目(2017G006019)。

摘　　要：糖尿病前期与多种疾病风险的增加有关,包括心血管疾病、微血管病变、肿瘤、痴呆以及抑郁等,是发展为糖尿病的必经阶段。近年来国内外对糖尿病前期的研究进展迅速,中华医学会内分泌学分会对原共识进行了更新和完善,发布了《中国成人糖尿病前期干预的专家共识(2023版)》,对指导我国糖尿病前期的筛查防治、规范临床综合管理、减缓糖尿病前期的进展具有重要的指导意义,本文对此版共识进行解读。Pre-diabetes is associated with an increased risk of diabetes,microvascular disease,cardiovascular and cerebrovascular disease,cancer,dementia,depression and other diseases,and is a necessary stage for the development of diabetes.In recent years,the research on pre-diabetes has made rapid progress both at home and abroad.Chinese Society of Endocrinology has updated and improved the original consensus,and released Intervention for adults with pre-diabetes:a Chinese expert consensus(2023 edition),which has significant value in guiding the screening,prevention,and treatment of pre-diabetes,standardizing clinical management,and slowing the progression of prediabetes in China.This article interprets this version of the consensus.

关 键 词：糖尿病前期 成人 干预 专家共识 解读 

分 类 号：R587[医药卫生—内分泌]